Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Connect Biopharma (CNTB US)
Watchlist
3
Analysis
Health Care
•
United States
Connect Biopharma Holdings Limited operates as a holding company. The Company, through its subsidiaries, focuses on developing therapies for the treatment of T cell-driven inflammatory diseases. Connect Biopharma Holdings serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Legend Biotech Corp
•
17 Apr 2022 17:51
Legend Biotech Corp (LEGN US): Carvykti Approval Is the Silver Lining Amid Uncertainty of Delisting
FDA approval of the company’s first drug Carvykti, with initial peak sales opportunity of $1.5 billion should be considered as a buy opportunity,...
Tina Banerjee
Follow
793 Views
Share
bearish
•
Meihua International Medical Technologies
•
05 Feb 2022 18:39
Meihua International Medical Technologies Pre-IPO: Risks Overshadow Cheap Valuation
Meihua plans to raise $50 million by offering 5 million shares. At midpoint, the company would command a market cap of $250 million. Shares are...
Tina Banerjee
Follow
359 Views
Share
bullish
•
Connect Biopharma
•
13 Mar 2021 22:37
Connect Biopharma IPO: Potent Medicine
Connect has launched a Nasdaq IPO to raise net proceeds of $135m at the mid-point of the IPO price range. Overall, we believe that the prospects of...
Arun George
Follow
289 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x